Phio Pharmaceuticals Corp. (PHIO)
1.32
+0.03
(+2.33%)
USD |
NASDAQ |
Apr 15, 16:00
1.30
-0.02
(-1.52%)
After-Hours: 07:55
Phio Pharmaceuticals Research and Development Expense (Annual) : 4.618M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 44.49M |
| Jaguar Health, Inc. | 24.97M |
| MetaVia, Inc. | 6.802M |
| Seastar Medical Holding Corp. | 7.518M |
| Jupiter Neurosciences, Inc. | 2.087M |